Global Colorectal Cancer Therapeutics Market Expected to Reach USD 16.58 billion at CAGR of 7.6% During the Forecast Period 2019-2026

(The Express Wire via Comtex)

The global “colorectal cancer therapeutics market” size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share and Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.

According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.

The report offers a comprehensive overview of the colorectal cancer therapeutics market analysis and its growth trajectories such as drivers, restraints, challenges, and opportunities. Besides that, the report provides a detailed segmentation of the market based on factors such as cancer type, by therapy, distribution channel, and others. It also offers the list of key colorectal cancer drugs market manufacturers and the prime strategies adopted by them to gain a competitive edge in the market.

Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/sample/colorectal-cancer-therapeutics-market-101945

Some of the keycolorectal cancer drugs marketmanufacturers include:

  • Novartis AG
  • Bayer AG
  • Merck Sharp and Dohme Corp.
  • Bristol Myers Squibb
  • Pfizer Inc.
  • Genentech, Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company

The report on theColorectal Cancer Therapeutics marketcontains:

  • Outstanding investigation of the market
  • Vital insights into the competitive landscape
  • Factors restricting market growth
  • Recent trends and development
  • Prime factors enabling growth
  • New government regulations

Quick BuyColorectal Cancer Therapeutics Market

https://www.fortunebusinessinsights.com/checkout-page/101945

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Colorectal Cancer Therapeutics Market Analysis 2021:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Colorectal Cancer Therapeutics MarketGrowth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Have Any Query? Ask Our Experts

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/colorectal-cancer-therapeutics-market-101945

Rescheduling of Effective Surgeries to Restrict Market Amid COVID-19

The postponement of selective and non-urgent surgeries by the government to administer COVID-19 patients has subsequently affected the growth of the market. According to COVIDSurg, around 28.4 million surgeries were canceled or postponed during the peak of 12 weeks of disruption due to COVIDé?19. Many companies operating in the market reported a major drop in revenue during the pandemic. For instance, Abbott’s neuromodulation segment reported a 30.1% decline in the global revenues during the first quarter of 2020 when compared to the same period in 2019. Similarly, the neuromodulation segment of Boston Scientific Corporation witnessed a 24.6% decline in sales globally during the first six months of 2020 when compared to the same period in 2019.

Colorectal Cancer Therapeutics Market Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Competitive and Regional Analysis:

This report focuses on Rheumatoid Arthritis Therapeutics Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

TheColorectal Cancer Therapeutics Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

In 2019, North America earned a revenue of USD 837.0 million and held the largest Colorectal Cancer Therapeutics Market share. A few factors responsible for this dominance are the presence of well-established healthcare infrastructure, a large target population, and high adoption of the latest diagnostic technologies. This, coupled with the increasing prevalence of chronic diseases, will also help this region continue dominating the market in the coming years.

Key questions answered in the report:

  1. What will the market growth rate of Colorectal Cancer Therapeutics Market in 2026?
  2. What are the key factors driving the global Rheumatoid Arthritis Therapeutics Market?
  3. Who are the key manufacturers in Colorectal Cancer Therapeutics Marketspace?
  4. What are the market opportunities, market risk and market overview of the Rheumatoid Arthritis Therapeutics Market?
  5. What are sales, revenue, and price analysis of top manufacturers of Rheumatoid Arthritis Therapeutics Market?
  6. Who are the distributors, traders and dealers of Rheumatoid Arthritis Therapeutics Market?
  7. What are the Colorectal Cancer Therapeutics Market opportunities and threats faced by the vendors in the global Colorectal Cancer Therapeutics Market industry?
  8. What are sales, revenue, and price analysis by types and applications of Rheumatoid Arthritis Therapeutics Market?
  9. What are sales, revenue, and price analysis by regions of Colorectal Cancer Therapeutics Market industry?

Table of Content

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Colorectal Cancer - By Key Countries, 2018
    • Pipeline Analysis, Key Players
    • Key Industry Developments
    • New Product Launches
    • Increasing RandD Initiatives in Colorectal Cancer Diagnostics
  • Global Colorectal Cancer Therapeutics Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Therapy
      • Targeted Therapy
      • Immunotherapy
      • Chemotherapy
      • Others
    • Market Analysis, Insights and Forecast By Cancer Type
      • Colorectal Adenocarcinoma
      • Gastrointestinal Carcinoid Tumors
      • Others
    • Market Analysis, Insights and Forecast By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Market Analysis, Insights and Forecast By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

ToC Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Global Colorectal Cancer Therapeutics Market Expected to Reach USD 16.58 billion at CAGR of 7.6% During the Forecast Period 2019-2026

comtex tracking

COMTEX_397751723/2598/2021-11-26T01:01:05